Tag: Dermatitis
With the development of new therapies, patients with atopic dermatitis (AD) will receive more effective treatment in the future, according to a recent study. AD is most often seen in children, leading to itchy, inflammatory skin. In many cases, childhood AD is linked with parental eczema, and is also the most common skin disease, with […]
Introduction Atopic dermatitis (AD), well-known as atopic eczema, is a long-term, pruritic, recurrent, systemic, inflammatory cutaneous disorder commonly linked with other atopic systemic diseases such as asthma, allergic rhinitis, and food allergy.1,2 Globally, 95% of cases with AD are detected before 5 years of age.1 Early diagnosis and timely treatment are pivotal in preventing AD […]
Dupilumab had an acceptable long-term safety and efficacy for adolescents with moderate to severe atopic dermatitis (AD), according to data from an open-label extension (OLE) phase 3 trial published in the American Journal of Clinical Dermatology. For adolescents (aged 12 to 18 years) with moderate to severe AD enrolled in the LIBERTY AD PED-OLE study, […]
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Document recommending Rinvoq (upadacitinib), from US drugmaker AbbVie (NYSE: ABBV), as a treatment of moderate to severe atopic dermatitis (AD) for adults and young people aged 12 and over, if the disease has not responded to at least […]